Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Cinven enters exclusive talks to acquire clinical nutrition leader Nutrisens from Sagard
Cinven enters exclusive talks to acquire clinical nutrition leader Nutrisens from Sagard Cinven has entered exclusive negotiations with Sagard MidCap to acquire Nutrisens, a France-based clinical nutrition specialist, in a deal that underscores the private equity...
Brookfield and Lunate launch $1bn residential JV targeting UAE and Saudi build-to-sell market
Brookfield and Lunate launch $1bn residential JV targeting UAE and Saudi build-to-sell market Brookfield Asset Management and Abu Dhabi-based investment firm Lunate have launched a $1bn joint venture to develop build-to-sell residential assets across the Middle East,...
Brigade and Macellum-backed $1bn Family Dollar carve-out appoints new CEO ahead of Q2 close
Brigade and Macellum-backed $1bn Family Dollar carve-out appoints new CEO ahead of Q2 close Family Dollar has named Duncan MacNaughton as chairman and CEO as the retailer prepares for its $1bn divestiture to Brigade Capital Management and Macellum Capital Management,...